Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells.

Abstract:

:Mdm2 is the major negative regulator of p53 tumor-suppressor activity. This oncoprotein is overexpressed in many human tumors that retain the wild-type p53 allele. As such, targeted inhibition of Mdm2 is being considered as a therapeutic anticancer strategy. The N-terminal hydrophobic pocket of Mdm2 binds to p53 and thereby inhibits the transcription of p53 target genes. Additionally, the C-terminus of Mdm2 contains a RING domain with intrinsic ubiquitin E3 ligase activity. By recruiting E2 ubiquitin-conjugating enzyme(s), Mdm2 acts as a molecular scaffold to facilitate p53 ubiquitination and proteasome-dependent degradation. Mdmx (Mdm4), an Mdm2 homolog, also has a RING domain and hetero-oligomerizes with Mdm2 to stimulate its E3 ligase activity. Recent studies have shown that C-terminal residues adjacent to the RING domain of both Mdm2 and Mdmx contribute to Mdm2 E3 ligase activity. However, the molecular mechanisms mediating this process remain unclear, and the biological consequences of inhibiting Mdm2/Mdmx co-operation or blocking Mdm2 ligase function are relatively unexplored. This study presents biochemical and cell biological data that further elucidate the mechanisms by which Mdm2 and Mdmx co-operate to regulate p53 level and activity. We use chemical and genetic approaches to demonstrate that functional inhibition of Mdm2 ubiquitin ligase activity is insufficient for p53 activation. This unexpected result suggests that concomitant treatment with Mdm2/Mdmx antagonists may be needed to achieve therapeutic benefit.

journal_name

Oncogene

journal_title

Oncogene

authors

Wade M,Li YC,Matani AS,Braun SM,Milanesi F,Rodewald LW,Wahl GM

doi

10.1038/onc.2011.625

subject

Has Abstract

pub_date

2012-11-08 00:00:00

pages

4789-97

issue

45

eissn

0950-9232

issn

1476-5594

pii

onc2011625

journal_volume

31

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Identification of a dominant-negative mutation in the yeast CDC25 guanine nucleotide exchange factor for Ras.

    abstract::In previous studies we changed five conserved amino acid residues in the catalytic domain of the yeast Ras-specific guanine nucleotide exchange factor CDC25GEF (Park et al., 1994). One of the substitutions (R1489E) resulted in a molecule which could bind Ras but was catalytically inactive. These observations suggested...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200893

    authors: Park W,Mosteller RD,Broek D

    更新日期:1997-02-20 00:00:00

  • Cooperative activity between HER oncogenes and the tumor suppressor IRF-1 results in apoptosis.

    abstract::The tumor suppressor transcription factor IRF-1 inhibits cell growth. In this report we show that IRF-1 also induces apoptosis of highly transformed and tumorigenic cell lines. This activity of IRF-1 is demonstrated with cell lines expressing HER oncogenes and an activatable IRF-1 fusion protein. Growth of cell lines ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202704

    authors: Kirchhoff S,Hauser H

    更新日期:1999-06-24 00:00:00

  • Restriction and complexity of Mcf2 proto-oncogene expression.

    abstract::MCF2/DBL is an X-linked proto-oncogene encoding a protein with a yet undetermined function. It can be activated in vitro by loss of 5' sequences in NIH3T3 bioassays; in vivo, deletion of the gene has been found in some hemophilia B patients. PCR analysis of its expression in mouse tissues shows a restriction to the go...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Galland F,Pirisi V,de Lapeyriere O,Birnbaum D

    更新日期:1991-05-01 00:00:00

  • Mutations of the p16 gene in gliomas.

    abstract::In the present study we investigated the frequency of p16 gene exon 2 mutations in 35 malignant gliomas, using either direct sequencing of the PCR products or cloning into the pCRII vector and sequencing of the cloned PCR products. No mutations were detected during direct sequencing of the PCR products. However, after...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kyritsis AP,Zhang B,Zhang W,Xiao M,Takeshima H,Bondy ML,Cunningham JE,Levin VA,Bruner J

    更新日期:1996-01-04 00:00:00

  • Ecotropic viral integration site 1, a novel oncogene in prostate cancer.

    abstract::Prostate cancer (PCa) is the most commonly diagnosed non-cutaneous cancer in men in the western world. Mutations in tumor suppressor genes and in oncogenes are important for PCa progression, whereas the role of stem cell proteins in prostate carcinogenesis is insufficiently examined. This study investigates the role o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.325

    authors: Queisser A,Hagedorn S,Wang H,Schaefer T,Konantz M,Alavi S,Deng M,Vogel W,von Mässenhausen A,Kristiansen G,Duensing S,Kirfel J,Lengerke C,Perner S

    更新日期:2017-03-01 00:00:00

  • Feline STK gene expression in mammary carcinomas.

    abstract::The human RON and its mouse homologue stk are members of the MET family of tyrosine kinase receptors. We have previously shown that the RON gene is over-expressed in human breast carcinomas. As cat mammary tumours have been proposed as a suitable model for aggressive human breast cancer, we identified the feline stk g...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205221

    authors: De Maria R,Maggiora P,Biolatti B,Prat M,Comoglio PM,Castagnaro M,Di Renzo MF

    更新日期:2002-03-07 00:00:00

  • Leukaemia lineage specification caused by cell-specific Mll-Enl translocations.

    abstract::Chromosomal translocations involving the Mixed-Lineage Leukaemia (MLL) gene underlie many human leukaemias and MLL rearrangements are found in both acute myelogenous and acute lymphoblastic leukaemias. To assess the functionally relevant haematopoietic cell contexts for MLL fusions to be tumorigenic, we have generated...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210818

    authors: Cano F,Drynan LF,Pannell R,Rabbitts TH

    更新日期:2008-03-20 00:00:00

  • Chimaerism and erythroid marker expression after microinjection of human acute myeloid leukaemia cells into murine blastocysts.

    abstract::It has been suggested that the embryonic microenvironment can control the survival and the transformed phenotype of tumour cells. Here, we addressed the hypothesis that the murine embryonic microenvironment can induce the differentiation of human tumour cells. To examine such interactions, we injected human leukaemic ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207134

    authors: Dürr M,Harder F,Merkel A,Bug G,Henschler R,Müller AM

    更新日期:2003-12-11 00:00:00

  • Genetics of melanoma predisposition.

    abstract::Predisposition to melanoma is genetically heterogeneous. Two high penetrance susceptibility genes, CDKN2A and CDK4, have so far been identified and mapping is ongoing to localize and identify others. With the advent of a catalogue of millions of potential DNA polymorphisms, attention is now also being focused on ident...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206445

    authors: Hayward NK

    更新日期:2003-05-19 00:00:00

  • A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis.

    abstract::Receptor tyrosine kinases of the Eph family are upregulated in several different types of cancer. One family member in particular, the EphA2 receptor, has been linked to breast, prostate, lung and colon cancer, as well as melanoma. However, mechanisms by which EphA2 contributes to tumor progression are far from clear....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208937

    authors: Fang WB,Brantley-Sieders DM,Parker MA,Reith AD,Chen J

    更新日期:2005-11-24 00:00:00

  • Mechanisms of the androgen receptor splicing in prostate cancer cells.

    abstract::Prostate tumors develop resistance to androgen deprivation therapy (ADT) by multiple mechanisms, one of which is to express constitutively active androgen receptor (AR) splice variants lacking the ligand-binding domain. AR splice variant 7 (AR-V7, also termed AR3) is the most abundantly expressed variant that drives p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.284

    authors: Liu LL,Xie N,Sun S,Plymate S,Mostaghel E,Dong X

    更新日期:2014-06-12 00:00:00

  • An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer.

    abstract::Lineage-restricted transcription factors (TFs) are frequently mutated or overexpressed in cancer and contribute toward malignant behaviors; however, the molecular bases of their oncogenic properties are largely unknown. As TF activities are difficult to inhibit directly with small molecules, the genes and pathways the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.517

    authors: Sulahian R,Casey F,Shen J,Qian ZR,Shin H,Ogino S,Weir BA,Vazquez F,Liu XS,Hahn WC,Bass AJ,Chan V,Shivdasani RA

    更新日期:2014-12-04 00:00:00

  • Characterization of the mouse Ron/Stk receptor tyrosine kinase gene.

    abstract::In an effort to understand the mechanisms governing the regulation of the mouse Ron receptor gene, a mouse genomic library was screened and overlapping clones coding for the Ron gene and flanking DNA were identified. Continuous DNA sequence was obtained for approximately 16.4 kilobases. The gene, from the initiator me...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201508

    authors: Waltz SE,Toms CL,McDowell SA,Clay LA,Muraoka RS,Air EL,Sun WY,Thomas MB,Degen SJ

    更新日期:1998-01-08 00:00:00

  • Involvement of caspase 3-activated DNase in internucleosomal DNA cleavage induced by diverse apoptotic stimuli.

    abstract::Degradation of chromosomal DNA into nucleosome-sized fragments is one of the characteristics of apoptotic cell death. Here, we examined whether caspase-activated DNase (CAD) is responsible for the DNA fragmentation that occurs upon exposure to various apoptotic stimuli. When human Jurkat cells were exposed to etoposid...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202868

    authors: McIlroy D,Sakahira H,Talanian RV,Nagata S

    更新日期:1999-08-05 00:00:00

  • Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies.

    abstract::Overexpression of the receptor tyrosine kinase ERBB2 (also known as HER2) occurs in around 15% of breast cancers and is driven by amplification of the ERBB2 gene. ERBB2 amplification is a marker of poor prognosis, and although anti-ERBB2-targeted therapies have shown significant clinical benefit, de novo and acquired ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.625

    authors: Shiu KK,Wetterskog D,Mackay A,Natrajan R,Lambros M,Sims D,Bajrami I,Brough R,Frankum J,Sharpe R,Marchio C,Horlings H,Reyal F,van der Vijver M,Turner N,Reis-Filho JS,Lord CJ,Ashworth A

    更新日期:2014-01-30 00:00:00

  • Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner.

    abstract::Although activating mutations of fibroblast growth factor receptor 3 (FGFR3) are frequent in bladder tumors, little information is available on their specific effects in urothelial cells or the basis for the observed mutation spectrum. We investigated the phenotypic and signaling consequences of three FGFR3 mutations ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.280

    authors: di Martino E,L'Hôte CG,Kennedy W,Tomlinson DC,Knowles MA

    更新日期:2009-12-03 00:00:00

  • Artemis is a negative regulator of p53 in response to oxidative stress.

    abstract::Artemis is a multifunctional phospho-protein with roles in V(D)J recombination, repair of double-strand breaks by nonhomologous end-joining and regulation of cell-cycle checkpoints after DNA damage. Here, we describe a new function of Artemis as a negative regulator of p53 in response to oxidative stress in both prima...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.100

    authors: Zhang X,Zhu Y,Geng L,Wang H,Legerski RJ

    更新日期:2009-06-04 00:00:00

  • Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection.

    abstract::TRAIL (TNF-related apoptosis-inducing ligand) induces apoptosis in susceptible cells by binding to death receptors 4 (DR4) and 5 (DR5). TRAIL preferentially induces apoptosis in transformed cells and the identification of mechanisms by which TRAIL-induced apoptosis can be enhanced may lead to novel cancer chemotherape...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204842

    authors: Clarke P,Meintzer SM,Spalding AC,Johnson GL,Tyler KL

    更新日期:2001-10-18 00:00:00

  • Apc deficiency predisposes to renal carcinoma in the mouse.

    abstract::Deregulation of Wnt signalling has recently been implicated in human renal cancer. Here, we directly test this association by using a Cre-LoxP strategy to inactivate the Adenomatous Polyposis Coli (Apc) gene in the murine renal epithelium. Mice homozygous for a conditional Apc allele were intercrossed with mice transg...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208956

    authors: Sansom OJ,Griffiths DF,Reed KR,Winton DJ,Clarke AR

    更新日期:2005-12-08 00:00:00

  • Mapping of MAX to human chromosome 14 and mouse chromosome 12 by in situ hybridization.

    abstract::The protein encoded by the MAX gene is a member of the class of basic region-helix-loop-helix-zipper proteins and has been demonstrated to associate with N-, L-, and c-Myc proteins both in vitro and in vivo. Heterodimers formed between c-Myc and Max proteins have been shown to possess sequence-specific DNA-binding act...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Gilladoga AD,Edelhoff S,Blackwood EM,Eisenman RN,Disteche CM

    更新日期:1992-06-01 00:00:00

  • Repression of cancer cell senescence by PKCι.

    abstract::Senescence is an irreversible growth arrest phenotype adopted by cells that has a key role in protecting organisms from cancer. There is now considerable interest in therapeutic strategies that reactivate this process to control the growth of cancer cells. Protein kinase-Cι (PKCι) is a member of the atypical PKC famil...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.524

    authors: Paget JA,Restall IJ,Daneshmand M,Mersereau JA,Simard MA,Parolin DA,Lavictoire SJ,Amin MS,Islam S,Lorimer IA

    更新日期:2012-08-02 00:00:00

  • The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.

    abstract::The E6 proteins of specific cancer-associated human papillomaviruses (HPVs) complex with and mediate degradation of the cellular anti-oncogene p53 in vitro. A critical property of p53 is its ability to stimulate transcription from promoters containing its recognition sequence. HPV E6, mutant p53 proteins, and several ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Mansur CP,Marcus B,Dalal S,Androphy EJ

    更新日期:1995-02-02 00:00:00

  • MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4.

    abstract::Murine double minute (MDM2) binding protein (MTBP) has been implicated in cancer progression. Here, we demonstrate one mechanism by which MTBP inhibits cancer metastasis. Overexpression of MTBP in human osteosarcoma cell lines lacking wild-type p53 did not alter primary tumor growth in mice, but significantly inhibite...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.69

    authors: Agarwal N,Adhikari AS,Iyer SV,Hekmatdoost K,Welch DR,Iwakuma T

    更新日期:2013-01-24 00:00:00

  • Proviral integrations at the Evi5 locus disrupt a novel 90 kDa protein with homology to the Tre2 oncogene and cell-cycle regulatory proteins.

    abstract::Evi5 is a common site of retroviral integration in T-cell lymphomas of AKXD mice. Mapping studies have localized Evi5 to a region approximately 18 kb upstream of another common viral integration site, Gfi1, on mouse chromosome 5 (Liao X, Jenkins NA and Copeland NG, (1995a). J. Virol., 69, 7132-7137). Gfi1 encodes a zi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200929

    authors: Liao X,Du Y,Morse HC 3rd,Jenkins NA,Copeland NG

    更新日期:1997-03-06 00:00:00

  • Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA.

    abstract::The Rel/NF-kappaB transcription factors regulate the expression of many genes. The activity of RelA, a member of the Rel/NF-kappaB transcription factor family, is constitutively activated in the majority of pancreatic adenocarcinomas and cell lines. We report that the urokinase-type plasminogen activator (uPA), one of...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202833

    authors: Wang W,Abbruzzese JL,Evans DB,Chiao PJ

    更新日期:1999-08-12 00:00:00

  • Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.

    abstract::Resistance to TGF-beta1 occurred in pancreatic cancer cells suggesting that inactivation of TGF-beta inhibitory signaling pathways may play an important role in human pancreatic cancer. The aim of our study was to determine the presence of alterations in the main putative components of the TGF-beta inhibitory signalin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202118

    authors: Villanueva A,García C,Paules AB,Vicente M,Megías M,Reyes G,de Villalonga P,Agell N,Lluís F,Bachs O,Capellá G

    更新日期:1998-10-15 00:00:00

  • Matrix metalloproteinase processing of PTHrP yields a selective regulator of osteogenesis, PTHrP1-17.

    abstract::Parathyroid hormone-related protein (PTHrP) is a critical regulator of bone resorption and augments osteolysis in skeletal malignancies. Here we report that the mature PTHrP1-36 hormone is processed by matrix metalloproteinases to yield a stable product, PTHrP1-17. PTHrP1-17 retains the ability to signal through PTH1R...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.70

    authors: Frieling JS,Shay G,Izumi V,Aherne ST,Saul RG,Budzevich M,Koomen J,Lynch CC

    更新日期:2017-08-01 00:00:00

  • Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.

    abstract::The transcription factor activator protein-1 (AP-1) has been implicated in a large variety of biological processes including cell differentiation, proliferation, apoptosis and oncogenic transformation. It is thought that the 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced AP-1 activity is because of the activation ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206102

    authors: Li J,Ma C,Huang Y,Luo J,Huang C

    更新日期:2003-01-16 00:00:00

  • Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain.

    abstract::Abundant levels of the hyperactive low molecular weight (LMW) forms of cyclin E contribute to deregulation of Cdk2 in breast tumors, but the mechanism through which they arise is not fully understood. Here, we explored the hypothesis that post-translational processing by a protease generates the LMW forms of cyclin E ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206166

    authors: Wang XD,Rosales JL,Magliocco A,Gnanakumar R,Lee KY

    更新日期:2003-02-06 00:00:00

  • DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.

    abstract::Sal-like protein 4 (SALL4), an embryonic stem cell transcriptional regulator, is re-expressed by an unknown mechanism in poor prognosis hepatocellular carcinoma (HCC), often associated with chronic hepatitis B virus (HBV) infection. Herein, we investigated the mechanism of SALL4 re-expression in HBV-related HCCs. We p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.399

    authors: Fan H,Cui Z,Zhang H,Mani SK,Diab A,Lefrancois L,Fares N,Merle P,Andrisani O

    更新日期:2017-04-27 00:00:00